rs782028471
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_005629.4(SLC6A8):c.1627G>A(p.Glu543Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,209,700 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 12 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E543Q) has been classified as Benign.
Frequency
Consequence
NM_005629.4 missense
Scores
Clinical Significance
Conservation
Publications
- creatine transporter deficiencyInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SLC6A8 | NM_005629.4 | c.1627G>A | p.Glu543Lys | missense_variant | Exon 12 of 13 | ENST00000253122.10 | NP_005620.1 | |
| SLC6A8 | NM_001142805.2 | c.1597G>A | p.Glu533Lys | missense_variant | Exon 12 of 13 | NP_001136277.1 | ||
| SLC6A8 | NM_001142806.1 | c.1282G>A | p.Glu428Lys | missense_variant | Exon 12 of 13 | NP_001136278.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SLC6A8 | ENST00000253122.10 | c.1627G>A | p.Glu543Lys | missense_variant | Exon 12 of 13 | 1 | NM_005629.4 | ENSP00000253122.5 | ||
| SLC6A8 | ENST00000430077.6 | c.1282G>A | p.Glu428Lys | missense_variant | Exon 12 of 13 | 2 | ENSP00000403041.2 | |||
| SLC6A8 | ENST00000485324.1 | n.1934G>A | non_coding_transcript_exon_variant | Exon 5 of 6 | 2 | |||||
| SLC6A8 | ENST00000413787.1 | c.*173G>A | downstream_gene_variant | 5 | ENSP00000400463.1 |
Frequencies
GnomAD3 genomes AF: 0.0000178 AC: 2AN: 112486Hom.: 0 Cov.: 25 show subpopulations
GnomAD2 exomes AF: 0.0000110 AC: 2AN: 182609 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000283 AC: 31AN: 1097214Hom.: 0 Cov.: 38 AF XY: 0.0000303 AC XY: 11AN XY: 362958 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000178 AC: 2AN: 112486Hom.: 0 Cov.: 25 AF XY: 0.0000288 AC XY: 1AN XY: 34678 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
- -
Creatine transporter deficiency Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 543 of the SLC6A8 protein (p.Glu543Lys). This variant is present in population databases (rs782028471, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with SLC6A8-related conditions. ClinVar contains an entry for this variant (Variation ID: 212212). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SLC6A8 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Creatine deficiency syndrome 1 Uncertain:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at